Cargando…
Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
Pathological complete response (pCR) after neoadjuvant chemotherapy (NCT) is associated with good long-term prognosis in breast cancer (BC) patients. However, some patients still recur and eventually die from this disease. For years, clinical stage at diagnosis has been consistently linked to recurr...
Autores principales: | Acevedo, Francisco, Walbaum, Benjamín, Muñiz, Sabrina, Petric, Militza, Martínez, Raúl, Guerra, Constanza, Navarro, Marisel, Córdova-Delgado, Miguel, Pinto, Mauricio P., Sánchez, Cesar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729290/ https://www.ncbi.nlm.nih.gov/pubmed/36477462 http://dx.doi.org/10.1038/s41598-022-25043-2 |
Ejemplares similares
-
Better overall survival in patients who achieve pathological complete response after neoadjuvant chemotherapy for breast cancer in a Chilean public hospital
por: Acevedo, Francisco, et al.
Publicado: (2021) -
Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer
por: Canteros, Daniel, et al.
Publicado: (2022) -
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data
por: Walbaum, Benjamín, et al.
Publicado: (2021) -
Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response
por: Li, Xianjun, et al.
Publicado: (2020) -
Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy
por: Weiss, Anna, et al.
Publicado: (2018)